In the present study, a series of 2-substituted-pyridines were synthesized and characterized by IR, 1 H-NMR and Elemental Analysis. The compounds were assayed against seizures induced by maximal electro shock (MES) and pentylenetetrazole (scMet). Neurologic deficit was evaluated by the rotarod test. The decrease in the elevated motor activity by introceptive chemical stimuli (amphetamine antagonistic activity) was studied at the dose level of 25 and 50 mg/kg, antihistaminic and cardiac activity were also studied. All the compounds exhibited significant anticonvulsant activity. Compounds 2-(2-piperazino-ethanoxy)pyridine, 2-(3-morpholino-2-hydroxypropyloxy)-pyridine, 2-(3-piperidino-2-hydroxypropyloxy)pyridine and 2-(3-piperazino-2-hydroxypropyloxy)pyridine were most active of the series against MES-induced seizures. Compounds 2-(2-piperazino-ethanoxy)pyridine, 2-(2-phenylamino-ethanoxy)pyridine, 2-(3-imidazolo-2-hydroxypropyloxy)pyridine, 2-(3-methylamino-2-hydroxypropyloxy)pyridine and 2-(3-piperidino-2-hydroxypropyloxy)pyridine exhibited significant decrease in the elevated motor activity at the dose of 50 mg/kg. Remarkable sympathetic blocking activity was observed with 2-(3-piperazino-2-hydroxypropyloxy)pyridine, 2-(3-piperidino-2-hydroxypropyloxy)pyridine and 2-(3-imidazolo-2-hydroxypropyloxy)pyridine only. Compounds 2-(2-morpholino-ethanoxy)pyridine, 2-(2-piperidino-ethanoxy)-pyridine, 2-(2-piperazino-ethanoxy)pyridine, 2-(2-imidazolo-ethanoxy)pyridine, 2-(2-diphenylamino-ethanoxy)-pyridine, 2-(2-diethanolamino-ethanoxy)pyridine, 2-(2-phenylamino-ethanoxy)pyridine and 2-(2-(4؆-hydroxy)-phenylamino-ethanoxy)pyridine exhibited significant blocking of histamine induced contraction on guinea pig ileum.
Pyridines were reported to possess anticonvulsant, 1, 2) cardiotonic, 3) antihypertensive, 4) b-adrenergic blocking activity. 5) Aryloxypropanolamines were reported to be associated with b-adrenergic blocking, 6, 7) CNS depressant 8) and hypotensive 9) activities. In view of the potential nature of these moieties, it was thought worthwhile to study the effects of two pharmacophoric moieties like pyridine and aryloxypropanolamine/aminoethane in a single molecule. We have reported the potential anticonvulsant activity of aryloxypropanolamine from our laboratory [10] [11] [12] [13] to continue our work in the same direction, it was envisaged that chemical entities with both pyridine and aryloxypropanolamine/ aminoethane moieties would result in compounds of interesting biological activities.
In the present study, we report the synthesis, the pharmacological evaluation, and structure-activity relationship of 2-(3Ј-substituted-2Ј-hydroxypropyloxy/2Ј-substituted-ethoxy)-pyridine. The compounds were characterized by IR, 1 H-NMR spectral and Elemental analysis. The compounds were investigated for anticonvulsant activity, the decrease in the elevated motor activity by introceptive chemical stimuli (amphetamine antagonistic activity) at the dose level of 25 and 50 mg/kg, cardiac activity on isolated frog heart and antihistaminic on guinea pig ileum. 1 H-NMR and IR spectra were consistent with the assigned structures.
Synthesis of 2-(2-Chloro-ethanoxy)pyridine 2-Hydroxy pyridine (0.1 mol) was added to 1,2-dichloro ethane (0.1 mol) and refluxed with potassium carbonate (0.02 mol) in methanol for about 40 h. On cooling the reaction mixture, the product was separated out, filtered, dried under vacuum and recrystallized by using chloroform-ether (1 : 1 General Method of Synthesis of 1 to 10 One hundredth moles of the corresponding 2-(2Ј-chloro-ethaneoxy)-pyridine was added to 0.01 mol of the appropriate amine in the presence of 20 ml of 5% alcoholic potassium hydroxide and refluxed for 10 h. On cooling, the products were separated, filtered, dried under vacuum and recrystallized using 1 : 1 acetone-diethyl ether (1, 2, 4), 1 : 1 ethanol-diethyl ether (3, 5, 7), 1 : 1 chloroform-diethyl ether (8, 10) and 1 : 1 methanoldiethyl ether (6, 9).
2-(2Ј-Morpholino-ethanoxy)pyridine 1: Yieldϭ45%, mp 150°C. General Method of Synthesis of 11 to 20 One hundredth moles of the corresponding 2-(2Ј,3Ј-epoxypropyloxy)-pyridine was added to 0.01 mol of the appropriate amine in the presence of 20 ml of 5% alcoholic potassium hydroxide and refluxed for 4 h. On cooling, the products were separated, filtered, dried under vacuum and recrystallized using 1 : 1 acetone-diethyl ether (13, 14, 20) 
PHARMACOLOGY
All the synthesized compounds were screened for anticonvulsant activity. The amphetamine antagonism was done at the dose of 25 mg and 50 mg/kg. The experimental dose for the amphetamine antagonism was selected between the minimal effective and maximal non-lethal dose. The compounds were also screened for the cardiac activity on isolated frog heart. All the compounds were soluble in water and administered to the animals as a solution in water for injection and triple glass distilled water. Wistar albino mice (18-25 g) and hartely guinea pig of either sex were procured from King Institute, Guindy, Chennai. They were kept in colony cages at 25Ϯ2°C, relative humidity 45-55% under 12 h light and dark cycle (0600 to 1800 h-light; 1800 to 0600 h-dark). All the animals were acclimatized for a week before use. Small frogs (Rana trigana, 80-120 g) were procured locally and used on the same day. Unpaired Student t-test 14) was performed to ascertain the significance of the exhibited activity.
Anticonvulsant Activity The compounds were tested for anticonvulsant activity by using the procedures described previously.
15) All compounds were tested for anticonvulsant activity with wistar albino mice (nϭ5) in the 18-25 g weight range. Each compound was administered intraperitoneally at three dose levels (30100 and 300 mg/kg). Three tests were performed for each compound; maximal electroshock (MES) induced convulsions, subcutaneous Metrozol (sc-Met) induced convulsions and rotarod neurotoxicity test (Tox). The compounds were made solution with water for injection.
Maximal electroshock seizures (MES) were induced 30 min after drug treatment by the application of 50 mA current for 0.2 s via corneal electrodes into the eyes. The protection was defined as the abolition of hind leg and tonic maximal extension component of the seizure. The subcutaneous pentylenetetrazole (Metrozol) seizure threshold test (sc-Met) was carried out by the subcutaneous administration of pentylenetetrazole (85 mg/kg). Animals were observed for over 30 min. Failure to observe the generalised clonic seizure is defined as protection.
Minimal neurotoxicity 16) (TD 50 ) was measured by the rotarod test (Tox) in mice. Wistar albino mice (nϭ4) were placed in 1-in. diameter knurled plastic rod rotating 6 rpm after administration of the drug, and their ability to maintain their balance was tested. Neurological deficit was indicated by the inability of the animal to maintain the equilibrium for 1 min on the rotating rod in each of three trials. The results are tabulated in Tables 1 and 2 .
Amphetamine Antagonistic Activity The decrease in the motor activity 17) induced by introceptine stimuli of the compounds was studied by amphetamine antagonism. Wistar albino mice (nϭ3) of either sex were selected by random sampling technique. The compounds were administered at a dose level 25 mg and 50 mg/kg i.p 30 min prior to the administration of amphetamine (5 mg/kg, i.p.). Phenobarbital (10 mg/kg, i.p.) was used as the standard drug. The motor activity of the compounds was observed for 15 min in an octophotometer (3 pair beam Photo Actometer; Inco Pvt. Ltd.; Mumbai; India) after 10 min of amphetamine administration. The percentage reduction of motor activity by the compounds are presented in Table 3 .
Cardiac Activity 18) Frogs were selected by random sampling technique. Isolated frog heart was mounted using normal amphibian ringer solution. Drugs may influence the rate and force of contraction of the heart. An increase in the force of contraction is called positive ionotropic and decrease in the force of contraction is marked as negative ionotropic. Force of the contraction was measured from the recordings of the frontal lever and they are denoted as negative and positive ionotropic. The effect of the compounds on the force of contraction was observed from 1 to 400 mg/dose. The effect of the compounds at various concentration with simultaneous administration of adrenaline (100, 200, 400 mg/dose) was also studied (Table 4) . 19) The terminal portion of the guinea pig ileum was dissected out from overnight fasted (water given ad libitum) healthy hartely strain of guinea pigs. Antihistaminic activity is based on the antagonism to the contraction of smooth muscle and the capillary dilation produced by histamine. The ileum was mounted by using tyrode solution bubbled with O 2 (95%) and CO 2 (5%) mixture at 37Ϯ0.5°C in the organ bath. Concentration dependent responses of histamine were recorded using frontal lever. Contact time of 30 s, and 5 min time cycle are kept for proper recording of the responses. The effect of the compounds (250, 500, 1000 mg/dose) on histamine-induced contractions was reported in Table 5 . Contractile re- sponses (given in table) are derived from the recordings of frontal lever.
Evaluation of Antihistaminic Activity

RESULTS AND DISCUSSION
The initial evaluation (phase I) of anticonvulsant activity of synthesized compounds presented in the Table I . The compounds were administered intraperitoneally at three doses (30, 100, 300 mg/kg).
As result of preliminary screening, compounds 1, 3, 4, 7, 9, 11-13, 16, 17, 19 and 20 were considered for the phase II trails. This provides an evaluation of the median effective dose (ED 50 ) and median neurotoxic dose (TD 50 ). Most of the compounds were active at 30 min but not at 4 h. These datas are shown in the Table 2 . Some of these derivatives showed high degree of protection against MES-induced seizures. But they were found to be less effective against scMet-induced seizures. Compound 13 was the best in the MES test having ED 50 of 36.3 mg/kg. In the MES test, the ED 50 of compounds was found to be 12 (39.3 mg/kg), 3 (45.5 mg/kg) and 11 (47.3 mg/kg).
The following structure-activity relationships were observed. In the propanol series (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) , only compounds 11-13, 16, 17, 19 and 20 were found to have a high degree of protection against MES-induced convulsions. Piperazino substituted compound at the 3rd position showed higher protection than the other heterocyclic substitution like morpholino, piperidino and imidazolo compounds. Among the tertiary amines, diethanolamino substituted at 3rd position offered more protection than other tertiary amino compounds (diethylamino, diphenylamino). Among the secondary amine substituted compounds methyl amino compound is more active than other compounds (phenylamino, 4-hydroxyphenylamino). In the ethane series (1-10), compounds 1, 3, 4, 7 and 9 were found to have high degree of protection against MES-induced seizures. Only heterocyclic (piperazino and imidazolo) groups substituted at the 2nd position showed more protection than the other substitution.
b-Blockers and aryloxypropanolamines 20) inhibit adenylyl cyclase, which reduces the production of c-AMP (adenosine mono phosphate). c-AMP activates the phosphorylation of hydroxyl (HO-) group containing aminoacids such as tyrosine, serine and threonine which causes the enzyme to change the shape, which causes the release of Ca 2ϩ . Since bblockers reduce c-AMP, less Ca ions are released. The propanol series of compounds may be correlated to the presence of the pharmacophore similarity to the chemical functionality present in b-adrenergic blocking agents. It may be hypothesized that the anticonvulsant activity exerted by some of the compounds by blocking Ca 2ϩ channels. Calcium influx via voltage-activated Ca 2ϩ channels also plays a role in epileptogenesis and neurodegenerative events, raising the possibility that the blockade of Ca 2ϩ channels may represent the mechanism of action of these compounds.
2, 3, 4, 8, 12-15 and 20 compounds exhibited significant decrease motor activity. The decrease in motor activity by the compounds with respect to ethane series (1-10) was found to be in the order of 3Ͼ8Ͼ2Ͼ4. Among the heterocyclic groups substituted at the 2nd position piperazine substituted compound is more active than piperidino and imidazolo substituted compounds. Morpholino substituted compound was found to be very much less potent than all the heterocyclic substituted compounds. None of the tertiary amines showed promising activity, Where as secondary amine substituted at the 2nd position, (phenyl amino) showed better activity. The decrease in motor activity by the compounds with respect to propanol series (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) was found to be in the order of 14Ͼ20Ͼ12Ͼ15Ͼ13. It was also observed that 2-OH substitution in the propane side chain plays a significant role in decrease of motor activity since hydroxyl group substituted compound 2 and 3 exhibited higher protection than the corresponding ethane compounds 12 and 13.
11-14, 16, 17 and 19 exhibited potential cardiac activity. None of ethane series compounds found to be active. Among the propanol series piperazino substituted compound showed better blocking activity than the other heterocyclic compounds where as all other compounds are less active than piperazino substituted compound. Among the tertiary amines substituted diphenyl and diethanolamino compounds are more active than the other compounds. 4-Hydroxyphenylamino, is more active among secondary amines. Electron pumping groups have prominent role in this effect. Proton pumping groups significantly downplayed the effect of blocking adrenaline in the entire series. The cardiac activity exhibited by these compounds may be correlated to the presence of the pharmacophore similarity to the chemical functionality present in b-adrenergic blocking agents. When administered concurrently with adrenaline, the compounds exhibited significant sympatholytic action. The compounds were able to block the effects of adrenaline (100, 200, 400 mg).
In the antihistaminic activity, almost all the ethane derivatives showed promising activity, whereas propanol series compounds found to be inactive. The active compounds were 1, 2, 4-6 and 8. Diethylamino and diphenylamino substituted compounds found to be more active in the entire series. This promising activity may be because of similarity of the functionality with other antihistaminic agents.
Irrespective of the aromatic moiety involved all the aryloxypropanolamines and aryloxyaminopropanes were found to possess anticonvulsant activities. Earlier we have reported the anticonvulsant activities and sympatholytic activities of b-pyridylaminopropanolamines.
10) Substituting b-pyridylamino with b-pyridyloxy does not influence both the activities much.
